Literature DB >> 21962816

Role for Gβγ G-proteins in protease regulation during remodeling of the murine femoral artery.

Yiping Zou1, Yuyang Fu, Mark G Davies.   

Abstract

BACKGROUND: Intimal hyperplasia remains the principal lesion in the development of restenosis after vessel wall injury. G-protein coupled receptors are involved in smooth muscle cell proliferation but the role of Gβγ in arterial intimal hyperplasia has not been well defined. The aim of this study is to characterize the expression of Gβγ G-proteins in the developing intimal hyperplasia in a murine model and the impact of disruption of Gβγ signaling on intimal hyperplasia development.
METHODS: The murine femoral wire injury model was employed. Specimens were perfusion-fixed and sections were stained with H&E and Movat's stains such that morphometry could be performed using an Image-Pro system. Additional specimens of femoral artery were also harvested and snap frozen for Western blotting for the Gβγ expression and for Western blotting and zymography to allow for the study of gelatinase and plasminogen activator expression and activation. Contralateral vessels were used as controls. Additional vessels were immersed in pluronic gel containing an adenovirus with the Gβγ inhibitor βARK(CT).
RESULTS: The injured femoral arteries developed intimal hyperplasia, while sham vessels did not produce such a response. Cell proliferation peaked at 3-5 d and cell migration at 7 d after injury. There was a marked time-dependent increase in Gβγ over the 28 d following injury. Inhibition of Gβγ with βARK(CT) inhibited cell proliferation, cell migration and the development of intimal hyperplasia. Inhibition of Gβγ decreased peak uPA activity and expression without increasing early PAI-1 activity and expression. Inhibition of Gβγ reduced peak MMP-2 activity at d 1 but not at d 7 and also reduced peak MMP-9 activity at d 3. Protein expression for both MMP-2 and MMP-9 was also transiently decreased. There were no changes in TIMP-1 and TIMP-2 expression and activity.
CONCLUSIONS: These data demonstrate a time-dependent increase in Gβγ G-protein expression following wire injury in the mouse. Inhibition of Gβγ alters cell proliferation and migration with associated changes in MMP-2, MMP-9, and uPA expression and activity.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21962816      PMCID: PMC3251654          DOI: 10.1016/j.jss.2011.08.006

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  31 in total

1.  Tissue inhibitor of matrix metalloproteinases-1 impairs arterial neointima formation after vascular injury in mice.

Authors:  H R Lijnen; P Soloway; D Collen
Journal:  Circ Res       Date:  1999 Dec 3-17       Impact factor: 17.367

2.  Targeting Gbeta gamma signaling in arterial vascular smooth muscle proliferation: a novel strategy to limit restenosis.

Authors:  G Iaccarino; L A Smithwick; R J Lefkowitz; W J Koch
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-30       Impact factor: 11.205

3.  Urokinase plasminogen activator enhances neointima growth and reduces lumen size in injured carotid arteries.

Authors:  O S Plekhanova; Y V Parfyonova; R Sh Bibilashvily; V V Stepanova; P Erne; A Bobik; V A Tkachuk
Journal:  J Hypertens       Date:  2000-08       Impact factor: 4.844

4.  Augmentation of proliferation of vascular smooth muscle cells by plasminogen activator inhibitor type 1.

Authors:  Yabing Chen; Ralph C Budd; Robert J Kelm; Burton E Sobel; David J Schneider
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-05-18       Impact factor: 8.311

5.  Plasma urokinase antigen and plasminogen activator inhibitor-1 antigen levels predict angiographic coronary restenosis.

Authors:  B H Strauss; H K Lau; K A Bowman; J Sparkes; R J Chisholm; M B Garvey; L L Fenkell; M K Natarajan; I Singh; J M Teitel
Journal:  Circulation       Date:  1999-10-12       Impact factor: 29.690

6.  Results of PREVENT III: a multicenter, randomized trial of edifoligide for the prevention of vein graft failure in lower extremity bypass surgery.

Authors:  Michael S Conte; Dennis F Bandyk; Alexander W Clowes; Gregory L Moneta; Lynn Seely; Todd J Lorenz; Hamid Namini; Allen D Hamdan; Sean P Roddy; Michael Belkin; Scott A Berceli; Richard J DeMasi; Russell H Samson; Scott S Berman
Journal:  J Vasc Surg       Date:  2006-04       Impact factor: 4.268

Review 7.  Vascular cell-derived fibrinolytic regulators and atherothrombotic vascular disorders (Review).

Authors:  G X Shen
Journal:  Int J Mol Med       Date:  1998-02       Impact factor: 4.101

8.  Patterns of gelatinase activation induced by injury in the murine femoral artery.

Authors:  Yiping Zou; Yan Qi; Elisa Roztocil; Mark G Davies
Journal:  J Surg Res       Date:  2008-06-23       Impact factor: 2.192

9.  Patterns of kinase activation induced by injury in the murine femoral artery.

Authors:  Yiping Zou; Yan Qi; Elisa Roztocil; Suzanne M Nicholl; Mark G Davies
Journal:  J Surg Res       Date:  2007-07-13       Impact factor: 2.192

10.  G Protein betagamma subunits augment UVB-induced apoptosis by stimulating the release of soluble heparin-binding epidermal growth factor from human keratinocytes.

Authors:  Miran Seo; Mi-Jeong Lee; Jin Hee Heo; Yun-Il Lee; Yeni Kim; So-Young Kim; Eun-So Lee; Yong-Sung Juhnn
Journal:  J Biol Chem       Date:  2007-06-04       Impact factor: 5.157

View more
  3 in total

1.  Effect of elastin-derived peptides on the production of tissue inhibitor of metalloproteinase-1, -2, and -3 and the ratios in various endothelial cell lines.

Authors:  Krzysztof Siemianowicz; Wirginia Likus; Tomasz Francuz; Wojciech Garczorz
Journal:  Exp Ther Med       Date:  2015-04-17       Impact factor: 2.447

2.  Effect of metabolic syndrome on the response to arterial injury.

Authors:  Yuyang Fu; Enrico A Duru; Mark G Davies
Journal:  J Surg Res       Date:  2014-05-27       Impact factor: 2.192

3.  Synergistic induction of cancer cell migration regulated by Gβγ and phosphatidylinositol 3-kinase.

Authors:  Eun Kyoung Kim; Sung Ji Yun; Jung Min Ha; Young Whan Kim; In Hye Jin; Dae Han Woo; Hye Sun Lee; Hong Koo Ha; Sun Sik Bae
Journal:  Exp Mol Med       Date:  2012-08-31       Impact factor: 8.718

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.